| Ranibizumab for neovascular age-related macular degeneration PJ Rosenfeld, DM Brown, JS Heier, DS Boyer, PK Kaiser, CY Chung, ... New England Journal of Medicine 355 (14), 1419-1431, 2006 | 7072 | 2006 |
| Ranibizumab versus verteporfin for neovascular age-related macular degeneration DM Brown, PK Kaiser, M Michels, G Soubrane, JS Heier, RY Kim, JP Sy, ... New England Journal of Medicine 355 (14), 1432-1444, 2006 | 4383 | 2006 |
| Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration JS Heier, DM Brown, V Chong, JF Korobelnik, PK Kaiser, QD Nguyen, ... Ophthalmology 119 (12), 2537-2548, 2012 | 2658 | 2012 |
| Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study DM Brown, M Michels, PK Kaiser, JS Heier, JP Sy, T Ianchulev Ophthalmology 116 (1), 57-65. e5, 2009 | 1727 | 2009 |
| The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole JS Duker, PK Kaiser, S Binder, MD de Smet, A Gaudric, E Reichel, ... Ophthalmology 120 (12), 2611-2619, 2013 | 1237 | 2013 |
| Intravitreal aflibercept for diabetic macular edema JF Korobelnik, DV Do, U Schmidt-Erfurth, DS Boyer, FG Holz, JS Heier, ... Ophthalmology 121 (11), 2247-2254, 2014 | 1024 | 2014 |
| Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies U Schmidt-Erfurth, PK Kaiser, JF Korobelnik, DM Brown, V Chong, ... Ophthalmology 121 (1), 193-201, 2014 | 952 | 2014 |
| Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ... Ophthalmology 118 (12), 2453-2460, 2011 | 889 | 2011 |
| HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists EB Dreyer, PK Kaiser, JT Offermann, SA Lipton Science 248 (4953), 364-367, 1990 | 731 | 1990 |
| Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies DM Brown, U Schmidt-Erfurth, DV Do, FG Holz, DS Boyer, E Midena, ... Ophthalmology 122 (10), 2044-2052, 2015 | 668 | 2015 |
| Acute endophthalmitis following intravitreal triamcinolone acetonide injection DM Moshfeghi, PK Kaiser, IU Scott, JE Sears, M Benz, JP Sinesterra, ... American journal of ophthalmology 136 (5), 791-796, 2003 | 626 | 2003 |
| Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis) PK Kaiser Transactions of the American Ophthalmological Society 107, 311, 2009 | 506 | 2009 |
| Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity SA Lipton, NJ Sucher, PK Kaiser, EB Dreyer Neuron 7 (1), 111-118, 1991 | 498 | 1991 |
| Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results PK Kaiser, DM Brown, K Zhang, HL Hudson, FG Holz, H Shapiro, ... American journal of ophthalmology 144 (6), 850-857. e4, 2007 | 484 | 2007 |
| Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies JS Heier, JF Korobelnik, DM Brown, U Schmidt-Erfurth, DV Do, E Midena, ... Ophthalmology 123 (11), 2376-2385, 2016 | 461 | 2016 |
| Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin-1-year results of a randomized clinical trial-VIP report no. 1 J Arnold, D Kilmartin, J Olson, S Neville, K Robinson, A Laird, ... Ophthalmology 108 (5), 841-852, 2001 | 428 | 2001 |
| Optical coherence tomographic patterns of diabetic macular edema BY Kim, SD Smith, PK Kaiser American journal of ophthalmology 142 (3), 405-412. e1, 2006 | 383 | 2006 |
| Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration PK Kaiser, BA Blodi, H Shapiro, NR Acharya, MARINA Study Group Ophthalmology 114 (10), 1868-1875. e4, 2007 | 289 | 2007 |
| Risk of inflammation, retinal vasculitis, and retinal occlusion–related events with brolucizumab: post hoc review of HAWK and HARRIER J Monés, SK Srivastava, GJ Jaffe, R Tadayoni, TA Albini, PK Kaiser, ... Ophthalmology 128 (7), 1050-1059, 2021 | 280 | 2021 |
| Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center MI Binder, J Chua, PK Kaiser, GW Procop, CM Isada Medicine 82 (2), 97-105, 2003 | 273 | 2003 |
Jeffrey Heier在 eyeboston.com 的电子邮件经过验证
